Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Nonrandomized, Non-interventional Trial to Evaluate ClearSight System Cardiac Output in China

NCT03807622 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03807622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03807622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Nonrandomized, Non-interventional Trial to Evaluate ClearSight System Cardiac Output in China
Lead sponsor
Edwards Lifesciences
Phase
Observational
Overall status
Completed
Start date
December 25, 2018
Completion date
October 17, 2019
Enrollment
125 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

patient with clinically indicated invasive monitoring